The active pharmaceutical ingredients (API) maker is also backed by ace investor Rakesh Jhunjhunwalal who died on Sunday. Jhunjhunwala holds over 24% stake in the firm through its investment arm Rare Enterprises
The active pharmaceutical ingredients (API) maker is also backed by ace investor Rakesh Jhunjhunwalal who died on Sunday. Jhunjhunwala holds over 24% stake in the firm through its investment arm Rare Enterprises